Clinical Trials Insight: 700042758

Trial Profile

Clinical Trials Insight: 700042758

Planning
Phase of Trial: Phase III

Latest Information Update: 14 Apr 2010

At a glance

  • Drugs Antithrombin alfa (Primary)
  • Indications Thrombosis
  • Focus Registrational; Therapeutic Use
  • Sponsors Lundbeck Inc; rEVO Biologics
  • Most Recent Events

    • 14 Apr 2010 Initiation of the trial is expected in the second half of 2010, according to a GTC Biotherapeutics media release.
    • 24 Mar 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top